Next Article in Journal
Palmitate and Stearate are Increased in the Plasma in a 6-OHDA Model of Parkinson’s Disease
Next Article in Special Issue
Ageing Investigation Using Two-Time-Point Metabolomics Data from KORA and CARLA Studies
Previous Article in Journal
Current Developments in µMAS NMR Analysis for Metabolomics
Previous Article in Special Issue
Alteration of Metabolic Pathways in Osteoarthritis
Article Menu
Issue 2 (February) cover image

Export Article

Open AccessArticle
Metabolites 2019, 9(2), 30;

MALDI-TOF-MS Analysis in the Identification of Urine Proteomic Patterns of Gestational Trophoblastic Disease

Gynecologic Oncology Department, Poznan University of Medical Sciences, Polna 33, 60-535 Poznan, Poland
Department of Inorganic and Analytical Chemistry, Poznan University of Medical Sciences, Grunwaldzka 6, 60-780 Poznan, Poland
Author to whom correspondence should be addressed.
Received: 20 November 2018 / Revised: 2 February 2019 / Accepted: 3 February 2019 / Published: 9 February 2019
(This article belongs to the Special Issue Metabolomics of Complex Traits)
Full-Text   |   PDF [3055 KB, uploaded 22 February 2019]   |  


Gestational trophoblastic disease (GTD) is a group of highly aggressive, rare tumors. Human chorionic gonadotropin is a common biomarker used in the diagnosis and monitoring of GTD. To improve our knowledge of the pathology of GTD, we performed protein-peptide profiling on the urine of patients affected with gestational trophoblastic neoplasm (GTN). We analyzed urine samples from patients diagnosed with GTN (n = 26) and from healthy pregnant and non-pregnant controls (n = 17) using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF-MS). Ions were examined in a linear mode over a m/z range of 1000–10,000. All GTN urine samples were analyzed before and after treatment and compared with those of the controls. The statistical analyses included multivariate classification algorithms as well as ROC curves. Urine sample analyses revealed there were significant differences in the composition of the ions between the evaluated groups. Comparing the pre-treatment and group with the pregnant controls, we identified two discriminatory proteins: hemoglobin subunit α (m/z = 1951.81) and complement C4A (m/z = 1895.43). Then, comparing urine samples from the post-treatment cases with those from the non-pregnant controls, we identified the peptides uromodulin fragments (m/z = 1682.34 and 1913.54) and complement C4A (m/z = 1895.43). View Full-Text
Keywords: gestational trophoblastic disease; biomarkers; MALDI-TOF-MS; protein–peptide profiling gestational trophoblastic disease; biomarkers; MALDI-TOF-MS; protein–peptide profiling

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

Banach, P.; Dereziński, P.; Matuszewska, E.; Matysiak, J.; Bochyński, H.; Kokot, Z.J.; Nowak-Markwitz, E. MALDI-TOF-MS Analysis in the Identification of Urine Proteomic Patterns of Gestational Trophoblastic Disease. Metabolites 2019, 9, 30.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Metabolites EISSN 2218-1989 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top